Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice

被引:0
|
作者
Pan, Ruangang [1 ]
Li, Pengfei [1 ]
Meyerholz, David K. [2 ]
Perlman, Stanley [1 ,3 ]
机构
[1] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Pathol, Iowa City, IA USA
[3] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; mouse adapted coronavirus; nsp4; nsp8; innate immune response;
D O I
10.1128/jvi.00584-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has resulted in substantial morbidity and mortality. The basis of severe disease in humans is difficult to determine without the use of experimental animal models. Mice are resistant to infection with ancestral strains of SARS-CoV-2, although many variants that arose later in the pandemic were able to directly infect mice. In almost all cases, viruses that naturally infected mice or were engineered to enable mouse infection required mouse passage to become virulent. In most cases, changes in structural and nonstructural changes occurred during mouse adaptation. However, the mechanism of increased virulence in mice is not understood. Here, using a recently described strain of mouse-adapted SARS-CoV-2 (rSARS2-MA30N501Y), we engineered a series of recombinant viruses that expressed a subset of the mutations present in rSARS2-MA30N501Y. Mutations were detected in the spike protein and in three nonstructural proteins (nsp4, nsp8, and nsp9). We found that infection of mice with recombinant SARS-CoV-2 expressing only the S protein mutations caused very mild infection. Addition of the mutations in nsp4 and nsp8 was required for complete virulence. Of note, all these recombinant viruses replicated equivalently in cultured cells. The innate immune response was delayed after infection with virulent compared to attenuated viruses. Further, using a lineage tracking system, we found that attenuated virus was highly inhibited in the ability to infect the parenchyma, but not the airway after infection. Together, these results indicate that mutations in both the S protein and nonstructural proteins are required for maximal virulence during mouse adaptation. IMPORTANCE Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus. Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus.
引用
下载
收藏
页数:13
相关论文
共 50 条
  • [1] Vandetanib Blocks the Cytokine Storm in SARS-CoV-2-Infected Mice
    Puhl, Ana C.
    Gomes, Giovanni F.
    Damasceno, Samara
    Fritch, Ethan J.
    Levi, James A.
    Johnson, Nicole J.
    Scholle, Frank
    Premkumar, Lakshmanane
    Hurst, Brett L.
    Lee-Montiel, Felipe
    Veras, Flavio P.
    Batah, Sabrina S.
    Fabro, Alexandre T.
    Moorman, Nathaniel J.
    Yount, Boyd L.
    Dickmander, Rebekah J.
    Baric, Ralph S.
    Pearce, Kenneth H.
    Cunha, Fernando Q.
    Alves-Filho, Jose C.
    Cunha, Thiago M.
    Ekins, Sean
    ACS OMEGA, 2022, 7 (36): : 31935 - 31944
  • [2] Dysbiosis in SARS-CoV-2-Infected Patients
    Marazzato, Massimiliano
    Ceccarelli, Giancarlo
    D'Ettorre, Gabriella
    GASTROENTEROLOGY, 2021, 160 (06) : 2195 - 2195
  • [3] Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice
    Gao, Wen-Cong
    Ma, Xin
    Wang, Peng
    He, Xiao-Yan
    Zheng, Yong-Tang
    Liu, Feng-Liang
    Zheng, Chang-Bo
    ZOOLOGICAL RESEARCH, 2021, 42 (05) : 633 - +
  • [4] Mapping and role of T cell response in SARS-CoV-2-infected mice
    Zhuang, Zhen
    Lai, Xiaomin
    Sun, Jing
    Chen, Zhao
    Zhang, Zhaoyong
    Dai, Jun
    Liu, Donglan
    Li, Yuming
    Li, Fang
    Wang, Yanqun
    Zhu, Airu
    Wang, Junxiang
    Yang, Wenhui
    Huang, Jicheng
    Li, Xiaobo
    Hu, Lingfei
    Wen, Liyan
    Zhuo, Jianfen
    Zhang, Yanjun
    Chen, Dingbin
    Li, Suxiang
    Huang, Shuxiang
    Shi, Yongxia
    Zheng, Kui
    Zhong, Nanshan
    Zhao, Jingxian
    Zhou, Dongsheng
    Zhao, Jincun
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (04):
  • [5] Captopril alleviates lung inflammation in SARS-CoV-2-infected hypertensive mice
    Wen-Cong Gao
    Xin Ma
    Peng Wang
    Xiao-Yan He
    Yong-Tang Zheng
    Feng-Liang Liu
    Chang-Bo Zheng
    Zoological Research, 2021, 42 (05) : 633 - 636
  • [6] Clinical Profile of SARS-CoV-2-Infected Neonates
    Kulkarni, Rajesh K.
    Valvi, Chhaya
    Dawre, Rahul
    Rajput, Uday
    Nagpal, Rema
    Deshmukh, Isha
    Kamath, Pragathi
    Harwani, Richa
    Srinivasarangan, Ramya
    Sonteke, Somendra
    Apoorva, R.
    Kamble, Savita
    Naik, Shilpa
    Bhosale, Ramesh
    Waghmare, Rakeesh
    Modi, Deepak
    Gajbhiye, Rahul
    Kinikar, Aarti A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (06)
  • [7] Intracellular peptides in SARS-CoV-2-infected patients
    Martucci, Luiz Felipe
    Eichler, Rosangela A. S.
    Silva, Renee N. O.
    Costa, Tiago J.
    Tostes, Rita C.
    Busatto, Geraldo F.
    Seelaender, Marilia C. L.
    Duarte, Alberto J. S.
    Souza, Heraldo P.
    Ferro, Emer S.
    ISCIENCE, 2023, 26 (09)
  • [8] Syncytia formation by SARS-CoV-2-infected cells
    Buchrieser, Julian
    Dufloo, Jeremy
    Hubert, Mathieu
    Monel, Blandine
    Planas, Delphine
    Rajah, Maaran Michael
    Planchais, Cyril
    Porrot, Francoise
    Guivel-Benhassine, Florence
    Van der Werf, Sylvie
    Casartelli, Nicoletta
    Mouquet, Hugo
    Bruel, Timothee
    Schwartz, Olivier
    EMBO JOURNAL, 2020, 39 (23):
  • [9] Upregulation of Neuroinflammation-Associated Genes in the Brain of SARS-CoV-2-Infected Mice
    Oh, Soo-Jin
    Kumari, Pratima
    Auroni, Tabassum Tasnim
    Stone, Shannon
    Pathak, Heather
    Elsharkawy, Amany
    Natekar, Janhavi Prasad
    Shin, Ok Sarah
    Kumar, Mukesh
    PATHOGENS, 2024, 13 (07):
  • [10] Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice
    Edin, Matthew L.
    Gruzdev, Artiom
    Graves, Joan P.
    Lih, Fred B.
    Morisseau, Christophe
    Ward, James M.
    Hammock, Bruce D.
    Bosio, Catharine M.
    Zeldin, Darryl C.
    FASEB JOURNAL, 2024, 38 (10):